Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.
about
The dopamine d1-d2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in Basal GangliaMolecular Pathways Bridging Frontotemporal Lobar Degeneration and Psychiatric DisordersBrain-derived neurotrophic factor epigenetic modifications associated with schizophrenia-like phenotype induced by prenatal stress in mice.BDNF deficiency and young-adult methamphetamine induce sex-specific effects on prepulse inhibition regulation.Is lead exposure in early life an environmental risk factor for Schizophrenia? Neurobiological connections and testable hypotheses.Working memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF overexpressing mice.Brain-derived neurotrophic factor (BDNF) Val(66)Met polymorphism differentially predicts hippocampal function in medication-free patients with schizophrenia.Genetic and epigenetic regulation of the brain-derived neurotrophic factor in the central nervous system.Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disordersDNA-methylation gene network dysregulation in peripheral blood lymphocytes of schizophrenia patients.Paranoid schizophrenia is characterized by increased CB1 receptor binding in the dorsolateral prefrontal cortexBrain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis.Genetic evidence for the association between the early growth response 3 (EGR3) gene and schizophreniaSerum brain-derived neurotrophic factor (BDNF) levels in schizophrenia: A systematic reviewMultiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunctionIncreases in [3H]muscimol and [3H]flumazenil binding in the dorsolateral prefrontal cortex in schizophrenia are linked to α4 and γ2S mRNA levels respectively.Neurodevelopment, GABA system dysfunction, and schizophreniaModeling the molecular epigenetic profile of psychosis in prenatally stressed mice.Genetics and function of neocortical GABAergic interneurons in neurodevelopmental disordersPeripheral BDNF: a candidate biomarker of healthy neural activity during learning is disrupted in schizophrenia.The NMDA receptor co-agonists, D-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex.Increases in two truncated TrkB isoforms in the prefrontal cortex of people with schizophreniaReciprocal Alterations in Regulator of G Protein Signaling 4 and microRNA16 in SchizophreniaFunctional Role of BDNF Production from Unique Promoters in Aggression and Serotonin Signaling.Dopamine receptor homooligomers and heterooligomers in schizophreniaMarkers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder.Neurotrophin signalling: novel insights into mechanisms and pathophysiology.Is altered BDNF biosynthesis a general feature in patients with cognitive dysfunctions?DNA methylation of the BDNF gene and its relevance to psychiatric disorders.Toward the identification of peripheral epigenetic biomarkers of schizophrenia.DNA methylation and demethylation as targets for antipsychotic therapy.Brain-Derived Neurotrophic Factor Expression in Individuals With Schizophrenia and Healthy Aging: Testing the Accelerated Aging Hypothesis of Schizophrenia.Expression and methylation of BDNF in the human brain in schizophrenia.Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia.Robust changes in expression of brain-derived neurotrophic factor (BDNF) mRNA and protein across the brain do not translate to detectable changes in BDNF levels in CSF or plasma.Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments.Altered CREB Binding to Activity-Dependent Genes in Serine Racemase Deficient Mice, a Mouse Model of Schizophrenia.Sex-specific disruptions in spatial memory and anhedonia in a "two hit" rat model correspond with alterations in hippocampal brain-derived neurotrophic factor expression and signaling.DNA methylation pattern of gene promoters of major neurotransmitter systems in older patients with schizophrenia with severe and mild cognitive impairment.A Novel Ultrasensitive In Situ Hybridization Approach to Detect Short Sequences and Splice Variants with Cellular Resolution.
P2860
Q21131063-1ED181A5-FF72-4C48-AD04-29C2DE716ED8Q26766487-D7159EE6-6844-4D6E-BBF8-8CC5B56987ECQ30416726-677905BF-6B6F-4124-BFD7-0BE39DE13E76Q30453396-C5B3933F-20C8-49B2-925E-EFF3C6211895Q30454141-0C3C03F5-9687-4776-9646-1FFA9405D77BQ30465290-D70A7283-5545-4E62-9DF5-59C873DE508DQ30586016-D629FA5D-A228-4A26-8704-D0CD7ADCCE1FQ33653087-4A662C7C-F145-4F93-9DB4-49FEC0875628Q33672712-CA3226D7-8289-480D-8954-5D405152987FQ34002660-42D149DA-3769-402E-875D-CE255428E5B5Q34026425-0A945514-0B4B-4EE7-A658-3B435175CD9FQ34132832-35B376FC-F90C-4DA2-84B0-3EAF18249573Q34140405-99D18353-21E8-4730-8FAC-F7E76D5C0120Q34347464-2BD30C1B-0C4D-4937-B6E8-2C6A5DF1DDD7Q34348224-20E1F381-3575-498B-8AAD-6874AF0857D3Q34548202-F21A5062-A9EA-4070-86C0-FCAB0FC99300Q34675943-5BBD021A-B1A8-4D2A-AAA0-7B5ABD7F7A08Q34815864-5E0B2495-7000-4F8A-8DD2-040DA031B7A3Q35173644-C9B94FCF-FCBE-416D-B2F3-7D941DB234F6Q35550864-26EF3426-6FB3-4888-9FE0-658AC8CA82E1Q35675159-BEBE212D-1B3B-48C6-ACCD-DE8F080718A2Q36471519-5222F582-797C-4204-836E-67491100993CQ36580028-35EC119C-9349-45F6-8BD6-8522025A00C0Q37006269-CFE88C77-958B-4A4B-A08C-E345FC4F1DC8Q37242424-C2E6AB2C-5B63-4CF3-AE2A-861250B3A773Q37621319-268C4463-B9B6-477C-87EA-B9B6F40F73F3Q37629100-93759D1F-AD99-4761-8956-3D3919A27C80Q38067671-EAD126F2-B6EB-4F8B-A45F-34BC657F3328Q38112245-3A8DCFAE-A9A1-4F3B-8A17-8E5AD5AE6527Q38202190-31ACBE0E-E597-4C51-A91F-E174A731D867Q38264416-AFCCD681-30D7-4322-8BEB-426E73C437E1Q38769563-D5A5F109-3BA4-495B-97B6-2453D1C5744CQ39315740-CD39987B-C1F3-43C2-B1F7-A2298FCAA51DQ43444866-904761D0-F420-4EAC-889C-459273DDE552Q44669549-C25FAF20-FECF-44E1-A227-ADF2E1661059Q47135096-2E53D7C7-B64F-407A-A731-A75141B7B298Q47367883-376B9D9C-57B1-4179-A0B9-6074F07A2422Q47879222-648EA8B3-FFA6-4C1E-92AE-490B49BF41C6Q48648416-158AE3B8-42F7-4AFF-8E08-4494D125F152Q49629866-CB28E705-688F-452C-A159-526CCF9DFB4B
P2860
Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.
@ast
Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.
@en
type
label
Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.
@ast
Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.
@en
prefLabel
Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.
@ast
Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.
@en
P2093
P2860
P1433
P1476
Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.
@en
P2093
A Deep-Soboslay
C Shannon Weickert
H L Cassano
J E Kleinman
P2860
P304
P356
10.1016/J.NEUROSCIENCE.2010.05.037
P407
P577
2010-05-27T00:00:00Z